Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 31,783 | 0.1% | 41,176 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 23,426 | 0.1% | 41,663 | 9/30/2025 |
| 2025 Q2 | 7/15/2025 | 22,334 | 0.1% | 42,540 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 27,582 | 0.1% | 43,489 | 3/31/2025 |
| 2024 Q4 | 2/19/2025 | 33,579 | 0.1% | 47,140 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 61,327 | 0.3% | 58,338 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 61,770 | 0.2% | 58,771 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 61,570 | 0.2% | 63,970 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 58,341 | 0.2% | 66,426 | 12/31/2023 |
| 2023 Q3 | 12/19/2023 | 54,536 | 0.2% | 66,268 | 9/30/2023 |
| 2023 Q2 | 12/19/2023 | 50,469 | 0.2% | 70,238 | 6/30/2023 |
| 2023 Q1 | 12/19/2023 | 50,492 | 0.2% | 61,450 | 3/31/2023 |
| 2022 Q4 | 12/19/2023 | 47,048 | 0.2% | 65,210 | 12/31/2022 |
| 2022 Q3 | 11/15/2022 | 43,537 | 0.2% | 63,201 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 37,845 | 0.2% | 64,022 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 44,406 | 0.2% | 63,580 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 39,704 | 0.1% | 62,870 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 38,540 | 0.1% | 63,684 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 35,480 | 0.1% | 63,522 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 30,070 | 0.1% | 63,555 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 29,458 | 0.1% | 60,976 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 31,929 | 0.2% | 57,039 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 34,986 | 0.2% | 56,098 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 22,047 | 0.2% | 45,151 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 18,445 | 0.1% | 49,123 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 19,316 | 0.1% | 64,327 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 19,553 | 0.1% | 71,038 | 12/31/2013 |